CoChat

Transport and Immune Functions of the Lymphatic System.

Open access
Davis, Michael J., Zawieja, Scott D., King, Philip D. · 2025 · Annual Review of Physiology

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index; 108 of the 192 sources its claims cite were checked for support.

Abstract

Two major functions of the lymphatic system are the reabsorption of excess interstitial fluid/protein and the coordination of immune cell interactions and trafficking. Specialized junctions between lymphatic endothelial cells optimize reabsorption. The spontaneous contractions of collecting vessels provide active lymph propulsion. One-way valves prevent backflow, and chemokine gradients direct the migration of immune cells. Specialized compartments within the lymph node facilitate antigen-immune cell interactions to produce innate and acquired immunity. Lymphatic injury and/or mutations in genes controlling vessel/valve development result in contractile/valve dysfunction, reduced immune cell trafficking and, ultimately, lymph-edema. Activated CD4+ T cells produce inflammatory mediators that exacerbate these processes, potentially leading to interstitial and lymphatic vessel remodeling and negatively impacting overall function. Mouse models have advanced our knowledge of lymphatic disease, but clinical trials to reduce the impact of inflammatory mediators have yielded mixed success, implying that additional factors underlying human lymphedema are not yet understood.

Overview

CoChat Summary

TL;DR

This review synthesizes how the lymphatic system's transport and immune functions depend on specialized lymphatic endothelial cell junctions, spontaneous collecting-vessel contractions, and competent one-way valves, and how their failure produces lymphedema. It argues that lymphatic injury or developmental mutations initiate a feedforward cycle in which CD4+ T cell–derived inflammatory mediators worsen contractile and valve dysfunction, while mouse models have over-predicted the success of anti-inflammatory therapy in patients.

Key findings

  • Lymphatic capillaries reabsorb excess interstitial fluid and protein via button-like LEC junctions and anchoring filaments; in humans daily lymph transport can exceed 8 L of fluid and 120 g of protein per day. Reabsorption is driven predominantly by a transient hydrostatic gradient when intraluminal pressure falls below interstitial pressure during the contraction cycle, not by an oncotic gradient.
  • Collecting vessels actively pump lymph: calculated ejection fractions often exceed 80%, and mouse popliteal vessel contraction frequency rises from ~2 to 20 contractions/min as pressure increases from 0.5 to 10 cmH2O (pressure-induced chronotropy). Valve closure depends strongly on diameter — when diameter is <50% of maximal, an adverse pressure gradient of <0.2 cmH2O suffices for closure, but near maximal diameter the required ΔP can increase >10-fold.
  • Immune cell entry into initial lymphatics is directed by CCL21/CCR7, S1P/S1PR1, integrins (ICAM-1, VCAM-1), and LYVE-1–hyaluronan–CD44 interactions; Tregs use lymphotoxin and neutrophils use MMP8/MMP9, elastase, and 12-HETE to disrupt button junctions. Lymph node egress is driven by S1P gradients reinforced by S1P lyase, with CD69-mediated S1PR1 removal retaining antigen-activated lymphocytes.
  • In lymphedema, CD4+ T cell–derived Th2 cytokines (IL-4, IL-13) reduce LEC viability and drive fibrosis; the mouse tail wound model shows reduced swelling with antibodies against CD4, IL-4, or IL-13. Clinical translation has been mixed: ketoprofen (NCT02257970), bestatin (NCT02700529), and anti-IL-4/IL-13 QBX258 (NCT02494206) did not reduce limb volume, whereas topical tacrolimus reduced limb volume in breast cancer lymphedema but did not significantly improve indocyanine green–assessed lymphatic function.

Methods

  • Narrative review article (Annual Review of Physiology, Vol. 87:151–172), synthesizing prior literature rather than presenting new primary data.
  • Evidence drawn from mouse and rat ex vivo and in vivo lymphatic preparations, single-cell transcriptome analyses of mouse collecting vessels and mesenteric LECs, cultured LEC studies, human lymphedema measurements (e.g., upright leg intralymphatic pressures), and phase 1/2 clinical trials.
  • Organized into sections on transport functions, immune functions, lymphatic dysfunction/lymphedema, summary points, and future directions.

Limitations

  • Stated by the paper: a dysfunctional or absent lymphatic vasculature in unchallenged mice does not produce gross tissue fluid accumulation or significant tissue failure, which the authors call a major shortcoming of mouse models and a rationale for large animal models; the extent to which IL-4, IL-13, TGFβ1, or other immune-derived pathways contribute to vessel remodeling in human lymphedema patients is unknown; the mechanistic basis of contractile adaptation to preload/afterload is unknown; whether striated muscle protein isoforms in LMCs are functionally important remains untested; and clinical trials targeting inflammatory mediators have yielded mixed success, implying additional unrecognized factors in human lymphedema.
  • Evident from the text: several key measurements rest on very few studies — collecting vessel permeability to albumin has been measured "only in a few studies," solute permeability in "a single study," and initial lymphatic permeability has not been systematically measured but is only estimated (three- to tenfold higher than collecting vessels). Transmission of suction upstream to capillary networks has not been demonstrated in vivo, and the role of the lymphatic glycocalyx in reabsorption or immune cell transmigration is not yet known.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1146/annurev-physiol-022724-104908

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

83 Valid · 13 Not valid · 42 Not checked · 46 Own results and interpretations

102 more claims · 48 with their cited sources checked

Create a free account to see all 184 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 65
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Citations

Cites

Show all 139 references

Research works printed but not linked: 10

  1. 2015, The role of the lymphatic system in cholesterol transport, Front. Pharmacol., 6, 182
  2. 2023, Characterization of the cellular components of mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells regulating lymphatic contractions, eLife, 12, RP90679
  3. 1984, Pressure-flow relations in blood and lymph microcirculation, 4, 251
  4. 2015, Experimental ileitis alters prostaglandin biosynthesis in mesenteric lymphatic and blood vessels, Prostaglandins Other Lipid Mediat, 116–117, 37
  5. 2024, Pacemaking in the lymphatic system, J. Physiol.
  6. 2008, Rate-sensitive contractile responses of lymphatic vessels to circumferential stretch, J. Physiol., 587, 165
  7. 2002, Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct, J. Physiol., 450, 1023
  8. 2024, Identifying peristaltic pacemaker cells in the upper urinary tract, J. Physiol
  9. 2008, Interstitial cells of Cajal: a new perspective on smooth muscle function, J. Physiol., 576, 721
  10. 2003, Molecular and functional analyses of the contractile apparatus in lymphatic muscle, FASEB J, 17, 920

Cited by

See all 42

Metadata

Authors
Davis, M. J., Zawieja, S. D., & King, P. D.
Affiliations
  • University of Missouri (US)
  • University of Michigan (US)
Venue
Annual Review of Physiology
Published
2025-02-10
Volume
87
Issue
1
Pages
151-172
ISSN
  • 0066-4278 (ISSN-L)
  • 1545-1585
OpenAlex
W4403678558
Cited by
42
References
139
Citations by year
2026: 30 · 2025: 12
FWCI
2.24
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Physiology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r00hl143198-04)
  • National Heart, Lung, and Blood Institute (R01HL146352, R01HL120888, R01HL122578, R00‐HL143198, R01HL141107)
Topics
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
Keywords
lymphatic system, lymphatic endothelial cells, lymphatic vessel contractility, lymph propulsion, chemokine gradients, immune cell trafficking, lymph nodes, lymphedema, CD4+ T cells, lymphatic remodeling, lymphatic disorders, lymphatic development
MeSH terms
Animals, Humans, Lymphatic System, Lymphedema, Lymphatic Vessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transport and Immune Functions of the Lymphatic System. https://app.cochat.ai/papers/10.1146/annurev-physiol-022724-104908
The paper
Davis, M. J., Zawieja, S. D., & King, P. D. (2025). Transport and Immune Functions of the Lymphatic System. Annual Review of Physiology. https://doi.org/10.1146/annurev-physiol-022724-104908

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.